Baxter won clearance to introduce its AMIA automated peritoneal dialysis (APD) system in the U.S. The device, designed with help from Dean Kamen’s DEKA Research and Development Corporation, is intended for home use, featuring a large screen that displays animated and voice guided step-by-step instructions on how to operate it.
On the clinical provider’s side, the system connects to Baxter’s SHARESOURCE system to upload treatment data and download any changes to the prescribed regimen. The patient’s physician can access SHARESOURCE at any time to see if the dialysis routine is being performed regularly and on time, making any changes as necessary remotely without even having to see the patient.
Following the FDA clearance, Baxter expects to be able to launch the AMIA before the end of this year.